Literature DB >> 3570054

Pelvic lymph node metastasis of uterine cervical cancer.

H Noguchi, I Shiozawa, Y Sakai, T Yamazaki, T Fukuta.   

Abstract

The state of pelvic lymph node metastasis was observed in 627 cases of Okabayashi's radical hysterectomy performed from 1950 to 1984 of which 589 cases with a known 5-year survival rate were examined according to their relationship to prognosis. The incidence of lymph node metastasis was 29.7%, becoming progressively higher with succeeding clinical stages. The metastasis rates according to site were 6.9% hypogastric nodes, 4.9% obturator nodes, 4.4% iliac nodes, and 25.0% parametrial nodes. Among the factors considered in the postoperative classification, lymph node metastasis demonstrated high values in cervical infiltration cancer, positive parametrial infiltration, positive vaginal invasion, and infiltration into the uterine body and L type of CPL classification. The 5-year survival rate was 83.0% in negative cases of pelvic lymph node metastasis, while in positive cases, it was as poor as 45.8%. Considering the relationship of various factors, it is shown that the presence of lymph node metastasis has a great effect on prognosis.

Entities:  

Mesh:

Year:  1987        PMID: 3570054     DOI: 10.1016/0090-8258(87)90287-3

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  An evaluation of chemotherapy in patients with cancer of the cervix and lymph node metastases.

Authors:  H T Ng; C C Yuan; Y Y Kan; E S Ho; M S Yen; K C Chao
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

2.  [18F]FDG-PET/CT and MRI for initial pelvic lymph node staging in patients with cervical carcinoma: The potential usefulness of [18F]FDG-PET/MRI.

Authors:  Philip Anner; Marius Mayerhöfer; Wolfgang Wadsak; Silvana Geleff; Robert Dudczak; Alexander Haug; Marcus Hacker; Georgios Karanikas
Journal:  Oncol Lett       Date:  2018-01-12       Impact factor: 2.967

3.  Tumor size and lymph node status determined by imaging are reliable factors for predicting advanced cervical cancer prognosis.

Authors:  Min Sun Kyung; Hong Bae Kim; Jung Yeob Seoung; In Young Choi; Young Soo Joo; Me Yeon Lee; Jung Bae Kang; Young Han Park
Journal:  Oncol Lett       Date:  2015-03-05       Impact factor: 2.967

4.  Preoperative PET/CT FDG standardized uptake value of pelvic lymph nodes as a significant prognostic factor in patients with uterine cervical cancer.

Authors:  Hyun Hoon Chung; Gi Jeong Cheon; Keon Wook Kang; Jae Weon Kim; Noh-Hyun Park; Yong Sang Song
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04       Impact factor: 9.236

5.  Abdominal radical trachelectomy guided by sentinel lymph node biopsy for stage IB1 cervical cancer with tumors >2 cm.

Authors:  Xiangyun Deng; Ying Zhang; Dapeng Li; Xiaoling Zhang; Hui Guo; Fei Wang; Xiugui Sheng
Journal:  Oncotarget       Date:  2017-01-10

6.  Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers.

Authors:  Israt Jahan; Jiro Fujimoto; Syed Mahfuzul Alam; Eriko Sato; Teruhiko Tamaya
Journal:  BMC Cancer       Date:  2008-10-20       Impact factor: 4.430

7.  Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers.

Authors:  J Fujimoto; H Toyoki; E Sato; H Sakaguchi; T Tamaya
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

8.  Who can benefit from a lymph node boost in definitive chemoradiotherapy for node-positive cervical cancer: an evaluation of nodal failure in patients without nodal boost.

Authors:  Haeyoung Kim; Won Park; Won Kyung Cho
Journal:  J Radiat Res       Date:  2020-05-22       Impact factor: 2.724

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.